Center for Scientific Review Notice of Closed Meetings
Summary
The NIH Center for Scientific Review published a Federal Register notice announcing four closed meetings scheduled for April 29 through May 1, 2026. The meetings will review grant applications for research in communication/language, biocontainment laboratories, biomaterials/nanoscience, clinical care interventions, and oncology fellowships. All meetings will be held virtually and closed to the public under exemptions for confidential trade secrets and personal privacy.
What changed
The notice invokes sections 552b(c)(4) and 552b(c)(6) of the Federal Advisory Committee Act to close these meetings, citing the need to protect confidential commercial information in grant applications and personal privacy of applicants. Four meetings are announced covering: Communication and Language review (April 29); UC7 National Biocontainment Laboratories evaluation (April 30); Special Topics in Biomaterials/Nanoscience/Gene-Drug Delivery (April 30); and Career Development Grants in Clinical Care/Health Interventions review (April 30-May 1).
No action is required from external parties. This is a routine administrative notice informing the public that peer review meetings will occur without public access. Grant applicants should note that their applications and associated discussions will be treated as confidential during the review process.
Archived snapshot
Apr 4, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Notice
Center for Scientific Review; Notice of Closed Meetings
A Notice by the National Institutes of Health on 04/06/2026
PDF
Document Details
Document Dates
- Table of Contents
- Public Comments
- Regulations.gov Data
- Sharing
- Document Statistics
- Other Formats
- Public Inspection Published Document: 2026-06657 (91 FR 17288) Document Headings ###### Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Communication and Language.
Date: April 29, 2026.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Andrea B. Kelly, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-6339, kellya2@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-AI-25-013: UC7 National Biocontainment Laboratories.
Date: April 30, 2026.
Time: 9:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting,
Contact Person: Stephanie Nicole Hicks, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-5710, hickssn@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Topics in Biomaterials, Nanoscience, and gene and drug delivery.
Date: April 30, 2026.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Poonam Tewary, Ph.D., Scientific Review Officer, BBBT Review Branch, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20852, (240) 532-9777, tewaryp@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Career Development Grants in Clinical Care and Health Interventions.
Date: April 30-May 1, 2026.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Christiane M Robbins, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, 6710B Rockledge Drive, Rm. 2121B, Bethesda, MD 20817, (301) 451-4989, crobbins@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Oncology.
Date: April 30-May 1, 2026.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Leila Bahadori Toulabi, Ph.D., Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W334, Rockville, MD 20850, (240) 276-6611, leila.toulabi@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; AD Research Centers.
Date: April 30-May 1, 2026.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Rekha Dhanwani, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9823, Rockville, MD 20892, (240) 627-3076, rekha.dhanwani@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Health Services Research: Developmental Disabilities, Mental Health, and Substance Use.
Date: April 30-May 1, 2026.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health, NIAID Rockville, MD 20892, shiv.prasad@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Topics in Social Influences and Environmental Determinants of Health.
Date: April 30, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications. ( printed page 17289)
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sandhya Sanghi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-2879, sandhya.sanghi@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in HIV Comorbidities and Clinical Studies.
Date: April 30, 2026.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Milene L Brownlow, Ph.D., Scientific Review Officer, The Center for Scientific Review, The National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (984) 287-3209, milene.brownlow@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-25-438: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional).
Date: April 30-May 1, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cynthia Chioma McOliver, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 594-2081, mcolivercc@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Dermatological Sciences.
Date: April 30, 2026.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kan Ma, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-4838, mak2@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Neurotherapeutic Agent Identification with Innovation Grants to Nurture Initial Translational Efforts (IGNITE).
Date: April 30, 2026.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Elizabeth Litvina, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1010E, Bethesda, MD 20892, (301) 272-0774, liza.litvina@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pain and Somatosensation.
Date: April 30, 2026.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Myongsoo Matthew Oh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1011F, Bethesda, MD 20892, (301) 435-1042, ohmm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: April 2, 2026.
Denise M. Santeufemio,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-06657 Filed 4-3-26; 8:45 am]
BILLING CODE 4140-01-P
Published Document: 2026-06657 (91 FR 17288)
Named provisions
Related changes
Get daily alerts for FR: National Institutes of Health
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FR: National Institutes of Health publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.